Galderma reports record first half 2026 net sales of 3.134 billion USD and 24.6% year-on-year growth at constant currency, raises net sales guidance for the full year Press release
Galderma launches Alastin® in Japan and key markets across Asia Pacific, expanding its footprint in the region Press release
Landmark global Galderma survey shows 9 out of 10 people are affected by skin quality concerns Press release
Galderma provides progress update regarding RelabotulinumtoxinA regulatory submission in the United States Press release
Galderma unveils new global survey data exploring the evolving expectations and experiences of patients and healthcare professionals with anti-wrinkle treatments Press release
Galderma receives U.S. FDA approval for Differin® Epiduo® Acne Gel Prescription-to-OTC switch Press release
Galderma reports strong start to the year, delivering first quarter 2026 net sales of 1.473 billion USD, growing 25.5% at constant currency Press release
Galderma launches new Alastin Regenerating Skin Nectar with TriHex+™, powered by its next-generation TriHex Technology® regenerative platform Press release
Interim data from two ongoing investigator-initiated trials highlight the role of Sculptra® and Restylane® in addressing aesthetic changes associated with weight loss medications and menopause Press release
